Close Menu

NEW YORK (GenomeWeb) — Co-Diagnostics announced today that it has regained compliance with Nasdaq's minimum stockholders' equity requirement, allowing its shares to continue to trade on the exchange.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.